Protection against stroke with glucagon-like peptide-1 receptor agonists: a comprehensive review of potential mechanisms
Abstract Several randomized controlled trials have demonstrated the benefits of glucagon-like peptide-1 receptor agonists (GLP-1RAs) on ischemic stroke in patients with diabetes. In this review, we summarize and discuss the potential mechanisms of stroke protection by GLP-1RAs. GLP-1RAs exert multip...
Gorde:
| Egile Nagusiak: | , , , , , , , |
|---|---|
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
BMC
2022-11-01
|
| Saila: | Cardiovascular Diabetology |
| Gaiak: | |
| Sarrera elektronikoa: | https://doi.org/10.1186/s12933-022-01686-3 |
| Etiketak: |
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|